Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey
Adam Fundytus(Queen's University), Christopher M. Booth(Queen's University), Lorenzo Moja(Istituti di Ricovero e Cura a Carattere Scientifico), Bishal Gyawali(Nagoya University Hospital), Dario Trapani(Harvard University), Dorothy Lombe, Richard Sullivan(King's College London), Elisabeth G.E. de Vries(University Medical Center Groningen), Felipe Roitberg(World Health Organization), Manju Sengar(Homi Bhabha National Institute), André Ilbawi, Wilma M. Hopman(Queen's University), Matthew Jalink(Queen's University)
Cited by 170
Related Papers
Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area
|JAMA|2003|1.4k
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830
HER2-Low Breast Cancer: Pathological and Clinical Landscape
|Journal of Clinical Oncology|2020|801